Comparable Metabolic Effects for E-Cigarettes, Smoking

This article originally appeared here.
Share this content:
Comparable Metabolic Effects for E-Cigarettes, Smoking
Comparable Metabolic Effects for E-Cigarettes, Smoking

WEDNESDAY, July 5, 2017 (HealthDay News) -- Electronic cigarette smoking has the same deleterious effect on weight and metabolic parameters as traditional cigarettes, according to research published online June 29 in Obesity Reviews.

Noting that smoking increases insulin resistance and contributes to other features of the metabolic profile, Ann A. Verhaegen, M.D., and Luc Van Gaal, M.D., Ph.D., from Antwerp University Hospital in Belgium, and colleagues examined the impact of e-cigarettes on metabolic parameters.

The researchers note that based on animal model experiments, e-cigarette smoking has similar effects as regular cigarette smoking on weight and metabolic parameters, even without nicotine exposure.

"Animal studies available today suggest that e-cigarette smoking has comparable deleterious effects on weight, body fat distribution, glucose and lipid parameters, and other cardiovascular risk factors as regular cigarettes, although they might be less pronounced," the authors write. "Until more human data are available, e-cigarette smoke should be used with caution, not only because of the pulmonary and carcinogenic effects, but also because of the possible cardiometabolic effects."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths